Pass Screening
Pass Screening - Related Videos
01:12
First Pass Effect
0 Views •
2023
Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs. Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
01:25
Single-pass Transmembrane Proteins
0 Views •
2023
Integral membrane proteins are tightly associated with the cell membrane and play a crucial role in cell communication, signaling, adhesion, and transport of the molecules. Some integral membrane proteins are present only in the membrane monolayer. For example, the enzyme fatty acid amide hydrolase is present in the cytoplasmic side of the membrane monolayer. In contrast, another type of integral membrane protein, also known as a transmembrane protein, spans across the membrane. Transmembrane...
01:23
Factors Influencing Bioavailability: First-Pass Elimination
0 Views •
2023
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
01:29
Insertion of Multi-pass Transmembrane Proteins in the RER
0 Views •
2023
The rough ER membrane synthesizes, assembles, and embeds transmembrane proteins in diverse topologies. These proteins function as transporters or channels and can remain in the ER membrane or are sent to the Golgi complex, lysosome, and cell membrane. The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
01:26
Insertion of Single-pass Transmembrane Proteins in the RER
0 Views •
2023
Integral membrane proteins are proteins adhered to the lipid bilayer of a cell organelle or membrane. They can be of two types: transmembrane integral proteins that span the lipid bilayer and monotopic proteins that are attached to either side of the membrane but do not pass through it. Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...
FAQs
Pass screening depends on predefined acceptance thresholds rather than on a result viewed in isolation. Investigators compare measurements such as enzyme activity, binding, purity, or signal intensity with values established from controls and reference standards. This comparison turns a raw assay result into a decision about whether the sample or condition warrants continued analysis.
Positive and negative controls provide the comparison framework needed to interpret a screening result. They help show whether the assay can produce an expected response and whether an apparent signal may be nonspecific or unreliable. Without these controls, researchers have less basis for deciding whether a measured activity, binding response, purity value, or signal intensity satisfies the acceptance criteria.
Signal strength alone does not guarantee a usable result. A condition may be excluded when its response is weak, nonspecific, or otherwise unreliable, even if another measurement appears favorable. Retesting can help determine whether the outcome reflects a genuine sample property or an inconsistent experimental result, protecting later analyses from being built on questionable data.
Investigators first establish acceptance criteria using appropriate controls and reference standards. They then measure the selected properties, which may include enzyme activity, binding, purity, or signal intensity, and compare each result with the predefined thresholds. Samples or conditions that meet the criteria continue to analysis, while unsuitable results are excluded or considered for retesting.
By separating acceptable results from weak, nonspecific, or unreliable ones, Pass screening directs attention toward samples and candidate compounds with sufficient evidence for continued study. This early selection reduces the effort spent on unsuitable material and helps organize later biochemical analyses around results that already meet established criteria.
Clear criteria and consistent control comparisons make decisions less dependent on subjective judgment. Applying the same standards to samples or experimental conditions helps identify unreliable outcomes before detailed characterization begins. This reduces wasted resources and supports more reproducible biochemical work by ensuring that later conclusions rely on results that passed an explicit quality-control step.